T Cell Adult Acute Lymphocytic Leukemia C0279592
A blood and bone marrow cancer where white blood cells multiply uncontrollably. Primarily affects adults and is treated with chemotherapy and sometimes stem cell transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Pallor
(hematologic)Fever
(general)Weight loss
(general)Priapism
(genitourinary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intensive Chemotherapy Regimen
Adult T-ALL requires intensive multi-phase chemotherapy adapted for adult physiology, typically including hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone with CNS-directed therapy.
Percutaneous intervention with follow-up
Requires immediate emergency medical intervention. Do not delay treatment.
BCR-ABL Tyrosine Kinase Inhibition
For Philadelphia chromosome-positive ALL, incorporation of TKIs like ponatinib or dasatinib with chemotherapy has dramatically improved outcomes and represents a new standard of care.
Additional treatment options
Consolidation with Allogeneic Transplant
Adults achieving remission are often candidates for allogeneic stem cell transplantation, particularly those with high-risk features or Ph+ disease, offering the best chance for durable remission.
surgicalMinimal Residual Disease Monitoring
Sensitive flow cytometry or molecular techniques to detect residual leukemia cells guide treatment intensification or deintensification decisions and predict relapse risk.
procedurePsychosocial Support Services
Professional psychological support addressing anxiety, depression, treatment adherence challenges, and survivorship concerns improves quality of life and may impact treatment outcomes in adult patients.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is T Cell Adult Acute Lymphocytic Leukemia C0279592?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. NCCN Guidelines. 2023.
Hoffbrand AV, Higgs DR, Keeling DM, et al. T-cell acute lymphoblastic leukemia in adults: advances in diagnosis and treatment. Blood Rev. 2021;35(4):100723.
Kantarjian H, Thomas D, O'Brien S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD) in adult acute lymphoblastic leukemia. Cancer. 2020;126(3):527-535.
Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Haematologica. 2022;107(6):1398-1409.
Medication Comparisons
Compare medications used to treat T Cell Adult Acute Lymphocytic Leukemia C0279592. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy